Rapid evolution of the neutralizing antibody response to HIV type 1 infection.


A recombinant virus assay was used to characterize in detail neutralizing antibody responses directed at circulating autologous HIV in plasma. Examining serial plasma specimens in a matrix format, most patients with primary HIV infection rapidly generated significant neutralizing antibody responses to early (0-39 months) autologous viruses, whereas… (More)


11 Figures and Tables

Slides referencing similar topics